infection and bleeding, painful mouth sores, nausea, loss of appetite, lethargy, and diarrhea. 4 High-intensity nursing care is required and oftentimes involves strict isolation procedures. 3 Loss of personal privacy, isolation from loved ones, negative self-image, financial concerns, and fear of treatment-related and disease-related morbidity and mortality all contribute to the emotional burden experienced by patients undergoing HSCT. 4, 5 Of note, mortality rates for patients receiving autologous HSCT range from approximately 15% (100 days) to 50% (6 years). 1 Consequently, psychological distress, including high anxiety and depressive symptoms, is common. [6] [7] [8] Meta-analyses and reviews of the effects of mind-body and psychosocial interventions for cancer patients suggest benefits in several areas, including emotional and functional adjustment, and treatment-and diseaserelated symptoms. 9-12 Although these interventions have been shown to help many cancer patients, most work has focused on the ambulatory setting. Despite the longstated need for research in this area with HSCT patients, 6 relatively few trials of interventions to enhance coping and minimize distress in adult patients undergoing HSCT have been identified. Syrjala and colleagues published 2 reports of similar interventions, hypnosis 13 and relaxation H ematopoietic stem cell transplantation (HSCT) is an aggressive treatment for many types of cancer, including hematologic and solid malignancies. In 2007, there were approximately 55 000 HSCTs done worldwide, with nearly one third done in the United States. 1 Nearly two thirds of all HSCTs are a type called autologous, which involves the ablation of a patient's bone marrow by high-dose chemotherapy with or without total body irradiation, followed by infusion of the patient's own mobilized peripheral stem cells. 2 Autologous HSCT is associated with less morbidity than the allogeneic type, involving a donor's marrow. Nonetheless, autologous HSCT is still fraught with considerable symptom distress and an average hospital stay of 3 weeks. 3 Common side effects evident during this hospitalization include risk of The hematopoietic stem cell transplant (HSCT) experience is emotionally and physically stressful for cancer patients who undergo this procedure. Mindfulness-based interventions have been studied in patients with various diagnoses, including cancer, although minimal work has applied this intervention to hospitalized patients. Use of mindfulness meditation has potential to provide HSCT patients with coping skills to deal with unpleasant symptoms and an uncertain future. This exploratory study examined feasibility, physiological arousal, and psychological and physical symptoms in HSCT patients participating in a mindfulness meditation intervention that begins before and continues throughout hospitalization and involves one-on-one guided sessions and daily practice using a 17-minute meditation CD. Of the 20 participants, 78.9% completed the intervention. Statistically significant decreases in heart and respiratory rates and improvements in symptoms immediately before and after each session were found. These findings demonstrate feasibility and preliminary support of a mindfulness meditation intervention with symptomatic, hospitalized cancer patients.
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Facing the Challenges of Hematopoietic Stem Cell Transplantation With Mindfulness Meditation: A Pilot Study
Keywords: mindfulness; meditation; MBSR; mind-body; bone marrow transplant; stem cell transplant; cancer with imagery, 14 with improvements from both for pain associated with HSCT, but not other symptoms, and no additional benefits with supplemental cognitive behavioral training. 13, 14 Another randomized study of 35 HSCT patients found significant decreases in anxiety and depression with participation in a relaxation breathing exercise program compared with control participants, although no improvements in leukocyte counts were identified. 15 Of note, many interventions are considered not feasible in the HSCT setting due to the high-intensity clinical care where patients' symptoms greatly limit their capacities for effort and concentration. Therefore careful consideration and evaluation of feasibility issues are paramount before implementing interventions in this setting.
Mindfulness meditation (MM) is a stress-reducing practice that involves intentionally paying attention to present-moment experience in a nonjudgmental way, thereby cultivating a stable and nonreactive awareness. 16 It aims to promote a sense of comfort with and acceptance of what is, rather than focusing on uncertainties of the future or past experiences. 16, 17 This intervention focuses on momentto-moment awareness of one's experiences, such as breathing, sound, and physical sensations. Mindfulness-based clinical programs, taught by trained health care professionals and done primarily in ambulatory group settings, have been used successfully to treat stress-related conditions in medical patients in ambulatory settings. 16, 18, 19 Critical reviews of research using mindfulness as an intervention with cancer outpatients identified its effectiveness in relieving physical and psychological symptoms. [20] [21] [22] [23] [24] However, minimal work has been done to apply this intervention among highly symptomatic and distressed patients experiencing an intense and lengthy hospitalization. If feasible, the integration of MM in the HSCT experience has potential to provide patients with coping skills to deal with unpleasant symptoms and an uncertain future.
The aims of this exploratory single-arm study were to (1) Examine the feasibility of an MM intervention that begins prior to and continues throughout hospitalization;
(2) Monitor physical and psychological symptoms and physiological arousal immediately before and after individualized MM sessions; (3) Assess procedural feasibility and psychometric properties of selected study instruments to be used in subsequent studies; and (4) Assess preliminary evidence of efficacy of the intervention in reducing symptom distress.
Methods
A National Cancer Institute-designated Comprehensive Cancer Center enrolled a convenience sample of 20 adult cancer patients who were scheduled for HSCT. Patients were approached for participation during their pretransplant appointment in the outpatient clinic. The study was approved by the appropriate institutional review board, and all patients participated in consent discussions and provided signed informed consent.
Intervention
As described in Table 1 , the intervention had 2 key components: one-on-one sessions with an MM instructor and listening to an audio CD. The intervention began on the day of apheresis (a blood collection procedure used to collect stem cells for infusion later during transplant hospitalization), which took place between 1 and 3 weeks before hospital admission. The intervention continued throughout hospitalization, which typically lasted 3 weeks.
An instructor met with the participant at apheresis and 1 or 2 times weekly throughout the hospitalization; each session lasted approximately 30 minutes. The instructors were trained health care professionals (registered nurses, psychologist, and chaplain) who completed the University of Massachusetts Mindfulness-Based Stress Reduction professional training program. 25 As part of the treatment fidelity, instructors maintained a log of the session details, which were discussed during weekly team meetings with a senior MM instructor. The team meetings provided for peer supervision and ensured consistency of intervention techniques.
The sessions were experiential: mindfulness techniques were taught through guided exercises that included awareness of breathing, different body sensations, thoughts, and emotions. Integrated throughout the sessions was the notion of how mindfulness techniques can be used in everyday activities, while in the hospital and at home. For example, an object awareness exercise (ie, eating ice chips) was introduced in the second session, so the participants could use this mindfulness technique later in the hospitalization when they have mouth sores and are limited to eating ice chips. Additionally, the sessions included exploring self-compassion through affirmations and phrases of loving-kindness, for example, May I be well and have a sense of vitality, right now in this moment. Such statements fostered receptivity toward learning the techniques and being actively involved in their own healing.
Participants also listened to a 17-minute guided meditation CD 26 that led patients through an awareness of breath, sound, physical sensations, and thoughts and feelings. The CD provided suggestions for experiencing each moment as it is, without judging or trying to change the experience. Participants were given the CD at apheresis and were encouraged to listen daily, starting that day and continuing throughout hospitalization. There were 2 reasons for starting the intervention before hospital admission: (1) This timing allowed for better habituation of MM skill practice because HSCT patients have better concentration and are less symptomatic and medicated before coming into the hospital Explanation of mindfulness meditation. Guided mindfulness experiential exercise using ice chips. Patient and instructor listened to the CD together and then briefly discussed the CD and the plan to listen to it. The instructor provided a general overview of study procedures to follow. They set up a time for the instructor to call the following week while at home. The instructor called the patient twice a week before hospitalization to answer any questions regarding the CD and to reinforce compliance. The first visit was on the second or third day of admission. Visits were generally in mid to late afternoon, because medical tests and procedures are usually done earlier in the day and visitors come in the evening. Family members could attend the mindfulness session, if present and the preference of both patient and family. Number of days between sessions were 2 to 4. Content of sessions included awareness of breathing, different body sensations, thoughts, and emotions as well as aspects of selfcompassion. Throughout the sessions, discussions included ways to integrate mindfulness practices into everyday life, while in the hospital for transplant and after discharge from the hospital. If patient was groggy or did not feel well, the instructor may still see the patient. The sessions do not require much effort on the part of the patient. For such times, the instructor used clinical judgment and shortened the time with the patient accordingly. Patient could refuse a visit from the instructor if he/she chose. A 17-minute CD, specifically about mindfulness meditation for cancer patients. Headphones, CD player, and batteries were provided, although the patient was also given option to listen to the CD without the headphones. Listening to the CD and initiating mindfulness practice was done before admission to the hospital for 2 reasons: (1) The preadmission period is stressful and beginning the mindfulness practice then could also be helpful in coping during that time; (2) Learning before coming into the hospital is more favorable, because there are likely fewer distractions and the patient would feel better earlier. The patient was encouraged to listen to the CD daily, from apheresis until discharge from the hospital. The patient could listen to the CD at any time of day that he/she chose. It was recommended to listen at times when distractions were known to be minimal. compared with during transplant hospitalization; and (2) Since patients commonly experience high anxiety in preparation for the HSCT, the MM techniques may help them cope better in the preparation period prior to hospitalization. Between apheresis and hospital admission, the instructor made a brief phone call twice per week to the participant; the purpose of the call was to check in and answer any questions about MM and the CD and to reinforce compliance (use of CD).
Measures
To assess feasibility of the intervention, we tracked participation in one-on-one sessions and their reported use of the meditation CD. We defined minimum criteria for feasibility as participating in 1 preadmission session and at least 1 session per week during hospitalization, and listening to the CD for at least 3 days per week. Listening to the mindfulness CD was assessed 2 ways: listening log and interview. The listening log consisted of a simple sheet of paper for each participant to note the date and time they listened to the CD. Participants were also interviewed throughout the hospitalization and were asked how often they had been listening to the CD.
To assess short-term changes in physical and psychological symptoms, participants completed standard 10 centimeter visual analogue scales (VAS)-one for each of the symptoms of comfort, anxiety, mood, and pain-immediately prior to and after each MM session. Participants rated their symptoms along a continuum by marking a line that best fit how they were feeling at that particular moment. Measures of physiological arousal, heart rate (radial pulse), and respiratory rate (rise and fall of abdomen) were also obtained within 5 minutes before and after individual sessions. Research staff obtained the heart and respiratory rates for 30 seconds; the amount counted at 30 seconds was then multiplied by 2 to determine rate per minute. Interrater reliability was determined for each of the research staff by an experienced registered nurse; at least 2 consecutive times they demonstrated and determined heart and respiratory rates with 100% accuracy.
To address procedural feasibility of administering instruments and to obtain preliminary evidence of efficacy of the intervention, a trained interviewer administered 20minute structured interviews at 6 time points: before starting intervention, days 2 and 10 of admission, day of discharge, and 30 and 100 days after discharge. Interviews were conducted by telephone before and after hospitalization, and in person during hospitalization. The interviews involved the completion of study instruments as well as questions about frequency of CD listening and perceptions about the MM intervention, including suggestions for changes in the intervention (ie, frequency and length of sessions, length and content of CD) for consideration in future research. 27 In addition to collecting background and demographic information at baseline, we administered 2 validated instruments at each time point: the Symptom Experience Scale (SES) 28 and the Hospital Anxiety and Depression Scale (HADS). 29 The SES consists of symptoms commonly experienced by cancer patients and describes symptom frequency, intensity, and distress, each rated on a 0 to 4 scale. Six subscales include nausea and appetite, fatigue and sleep, concentration, appearance, bowel function, and pain. The HADS is a 14-item self-report measure with two 7-item subscales assessing anxiety and depression, or a combined total score of psychological distress. It is a well-established instrument with cancer populations. 30 On both instruments, higher scores indicate greater symptom or psychological distress, respectively.
Analysis
To aid in assessing feasibility and describing compliance, the number of MM instructor sessions and self-reported frequency of CD use were quantified. The Wilcoxon signed-rank test was used to test for differences between pre-and posttreatment VAS, pulse, and respiratory rate measurements at each intervention session. Because MM sessions were not conducted at fixed time points, longitudinal modeling of these data was not performed. Instrument reliability was assessed by estimating Cronbach's alpha coefficient for each time point of SES and HADS administration. Change over time in the SES and HADS was tested using withinsubject repeated measures ANOVA.
Results
Of the 23 patients approached, 20 consented (87% recruitment rate) to participate (5 men, 15 women, mean age = 51 years [SD = 10]). Participant characteristics were as follows: 95% Caucasian, 65% married or in a committed relationship, 40% had no children, 50% had some college or college degree, and 25% also had an advanced degree. One patient became ineligible to continue shortly after consenting (transplant was not done as planned) but did complete the intervention at apheresis. Therefore, this patient's data were used to explore the effect of the intervention at that time, but they were excluded from the denominator in calculating compliance and were therefore not used to assess feasibility.
The majority of participants (78.9%) completed the MM intervention based on the defined feasibility criteria (95% exact confidence interval [54%, 94%]). Of the 4 participants who did not complete the intervention, 1 participated in an appropriate number of sessions with the instructor; however, she did not listen to the CD; 3 participants used the CD as recommended and completed 3 out of a possible 4 minimum sessions. The 1 participant who didn't listen to the CD indicated that she didn't like it; this person was female and the youngest participant (23 years old). The reasons why the other 3 participants didn't complete the minimum number of instructor sessions were due to not feeling well or feeling too sleepy. CD listening log data were not analyzed, because every participant admitted that they did not keep up with this documentation; reasons for not documenting with the listening log were forgetting to do it, too sick, and lost the log. However, most participants reported listening to the meditation CD throughout the intervention period, based on patient interview data. During the prehospital admission period, 89.5% listened to the CD at least 3 times. In-hospital assessments identified that all but 1 participant (94.7%) reported listening to the CD at least 3 times each week, with 55% listening to it "every day or nearly every day."
Overall, the intervention was relatively easy to implement, both in the apheresis and hospital units. Even when the patients felt their worst (on hospital days 7-10), they were generally receptive to meeting with the instructor as well as being interviewed by the research staff to complete the questionnaires. The nursing and medical staff were supportive of the patient's time to meet with the instructor and to listen to the CD. Before each session, the instructor checked with the participant's nurse to be sure the timing and patient's condition were acceptable to conduct the session. A sign was then posted on the door to the participant's hospital room, "Session in Progress, Do Not Disturb." Nonetheless, there were occasional episodes when hospital staff would come into the room or machines (ie, intravenous infusion pump) would alarm. During such occasions, the instructor would incorporate the interruptions into the guided mindfulness experience.
Data collection procedures were also shown to be feasible, with 94.7% staying in the study and completing data collection throughout hospitalization. Sixteen (84%) completed 5 data collections (to day 30 postdischarge), and 15 (79%) completed all 6 data collection points (to day 100). The reasons for attrition were too ill or died (4 patients), and 1 was lost to follow-up.
The impact of the MM intervention was evaluated by examining post-versus pre-MM differences in symptoms; VAS were administered both immediately before and after each individual session with the MM instructor. As shown in Figure 1 , relaxation, comfort, happiness, and pain levels were found to be statistically significantly improved at most sessions via a two-sided Wilcoxon signed-rank test (α = .05). Also, statistically significant decreases in both heart and respiratory rates were consistently observed: the median post-versus pre-MM change in heart rate at session 1 was a decrease of 6 beats per minute (S = -42.5; P = .0045), and the median respiratory rate change was a decrease of 2 breaths per minute (S = -22.5; P = .0039). These data are typical of those found at each session.
The HADS and SES demonstrated good to excellent reliability, with the standardized Cronbach alpha statistic ranging from 0.70 to 0.82 for the HADS and 0.80 to 0.91 for the SES. Mean HADS total scores (±SE) were 10.1 ± 1.1, 10.1 ± 1.2, 9.7 ± 1.3, 7.4 ± 1.2, 5.0 ± 1.3, and 4.3 ± 0.9 for each of 6 fixed data collection points, respectively, suggesting that the greatest levels of psychological distress were at apheresis and admission, after which the mean HADS scores remained the same or declined. A withinsubjects, repeated measures ANOVA was used to assess the significance of the changes in mean HADS scores over time. In this model, the fixed effect of time was significant (P < .0001; F = 7.93, 5/80 df). Mean SES scores (±SE) were 27.7 ± 3.0, 27.9 ± 3.3, 37.6 ± 2.6, 31.1 ± 3.5, 13.2 ± 2.2, and 11.5 ± 2.3 for the 6 (respective) fixed data collection points, suggesting a peak in symptom distress on day 10, followed by a sharp drop at 30 days after discharge. In the repeated measures ANOVA, the fixed effect of time was significant (P < .0001; F = 21.39, 5/79 df).
Discussion
This pilot study demonstrated that a MM intervention is a feasible and potentially effective approach to reducing physical and psychological symptom distress among patients undergoing HSCT. The high recruitment and completion rates suggest this approach was well-accepted and within patients' ability to perform, even under very stressful and challenging treatment conditions and a complex clinical environment. In addition, this study demonstrated that short-term and long-term changes in symptoms were measurable in this population, and chosen measures were feasible to administer.
Our findings of improvements in psychological and physical well-being are consistent with other mindfulnessbased interventions with cancer outpatients [31] [32] [33] and other medical patients in ambulatory settings. 34, 35 The unique characteristics of our project compared with others to date is our study is the first to be done in an intense inpatient clinical setting using one-on-one sessions as compared with the traditional mindfulness-based stress-reduction programs done with groups in clinics or in the community.
There are limitations to this study, most notably the small convenience sample and the lack of control group to assess the impact of the intervention. This study demonstrated significant and consistent effects of the intervention on participants' short-term levels of symptoms and distress as well as heart and respiratory rates at each individual session. The observed changes may be due to the presence of another human being, rather than the intervention itself; therefore, future research will include an attention control condition. Based on the literature, one would expect the natural course of treatment and recovery to show greater distress during hospitalization and less distress after discharge. 36, 37 Therefore, without a comparison group, we do not know the additional intervention effect, if any, on symptoms over time. Future randomized trials will provide evidence of the longitudinal effects, if any, of the intervention group versus a comparison group. Although the instructors were well trained and monitored closely with regular peer supervision meetings, treatment fidelity is limited because the intervention sessions were not recorded. Additionally, given that participants did not reliably maintain written CD listening logs, the full extent of mindfulness practice cannot be determined. More objective documentation of CD listening, that is, electronic logger, would have been superior to relying on subjective reporting.
Given that our instructors all received special training and supervision to teach mindfulness meditation to patients, generalizability of this intervention to average clinicians in most hospitals is limited. However, with further research, if distinct benefits of the intervention are identified, then training of hospital staff, particularly bedside nurses, could be supported. As such there would be potential for nurses and doctors to eventually integrate mindfulness techniques into everyday care of patients.
In conclusion, this pilot study is the first research of a mindfulness-based intervention done in acutely ill hospitalized patients. Our findings are encouraging and provide evidence of its feasibility and potential benefits to reduce distress and improve quality of life among cancer patients who are undergoing this very physically and emotionally challenging treatment.
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